Israel - heprea - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 40 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

Israel - heprea - Ministry of Health

pfizer pharmaceuticals israel ltd - amlodipine as besylate 10 mg; atorvastatin as calcium 80 mg - film coated tablets - amlodipine - caduet (amlodipine and atorvastatin ) is indicated in patients for whom treatment with both amlodipine and atorvastatin is apptopriate. amlodipine: - hypertension - chronic stable angina - vasospastic angina (prinzmetal's or variant angina). atorvastatin : - prevention of cardiovascular disease - heterozygous familial and nonfamilial hypercholesterolemia - elevated serum tg levels - primary dysbetalipoproteinemia - homozygous familial hypercholesterolemia - pediatric patients (10-17 years of age) : atorvastatin is indicated as an adjunct to diet to reduce total -c ldl-c and apo b levels in boys and postmenarchal girls 10 to 17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: 1. ldl-c remains >or = 190 mg/dl or 2. ldl-c remains > or = 160 mg/dl and: there is a positive family history of premature cardiovascular disease or two or more other cvd risk factors are present in the pediatric patient.

Israel - heprea - Ministry of Health

teva pharmaceutical indust.ltd - amlodipine as besylate 10 mg - tablets - amlodipine - mild to moderate hypertension. vasospastic angina (prinzmetal's or variant angina ). chronic stable angina.

Israel - heprea - Ministry of Health

novartis israel ltd - baclofen - טבליה - baclofen 10 mg - baclofen - baclofen - muscle spasticity of various origins.

Israel - heprea - Ministry of Health

teva pharmaceutical industries ltd, israel - diazepam - תמיסה להזרקה - diazepam 10 mg / 2 ml - diazepam - diazepam - symptomatic relief of tension and anxiety either alone or when associated with stressful situations. psychoneurotic states manifested by tension, anxiety, apprehension, fatigue and depressive symptoms. in acute alcohol withdrawal, assival may be useful in the symptomatic relief of tremor, impending or acute delirium tremens and hallucinosis. assival is a useful adjunct in the relief of skeletal muscle spasm, spasticity, stiffman syndrome and tetanus. when used intravenously, assival injection is a useful adjunct in status epilepticus and severe recurrent convulsive seizures. as premedication in patients undergoing surgical procedures (the intramuscular route is preferred) or in patients undergoing cardioversion (when the intravenous route is preferred).

Israel - heprea - Ministry of Health

teva pharmaceutical industries ltd, israel - oxolamine citrate - סירופ - oxolamine citrate 1 g / 100 ml - oxolamine - oxolamine - acute and chronic infections of respiratory tract with cough: bronchitis, tracheitis, laryngotracheitis, spastic bronchitis, pertusis, smoker's cough and cough complicating the common cold.